REQUEST A DEMO
Total
USD $0.00
Search more companies

Tri Medical Company Limited (Thailand)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Tri Medical Company Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Tri Medical Company Limited is an enterprise based in Thailand. Its main office is in Bangkok , Special Governed District of. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was first established on June 01, 2026. 8 (2024) employees currently work for Tri Medical Company Limited. From the latest financial highlights, Tri Medical Company Limited reported a net sales revenue increase of 40.6% in 2024. Its’ total assets recorded a growth of 7.31%. The enterprise’s net profit margin increased by 2.99% in 2024.

Headquarters
809/4 Soi S.Thoranin 8
Bangkok , Special Governed District of; Central Thailand; Postal Code: 10310

Contact Details: Purchase the Tri Medical Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the Tri Medical Company Limited report to view the information.
Financial Auditors:
Purchase the Tri Medical Company Limited report to view the information.
Incorporation Date:
June 01, 2026
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Managing Director
Company Performance
Financial values in the chart are available after Tri Medical Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
40.6%
Total Operating Revenue
41.28%
Operating Profit
130.64%
EBITDA
130.64%
Net Profit/Loss for the Period
240.41%
Total Assets
7.31%
Total Equity
32.2%
Operating Profit Margin
3.65%
Net Profit Margin
2.99%
Return on Equity (ROE)
14.9%
Debt / Equity
-60.99%
Quick Ratio
0.02%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?